Franklin Genomic Advancem... (HELX)

Cboe US: HELX · Echtzeitkurs · USD

43.51

+1.07 (2.52%)

Zum Schluss: Aug 27, 2026, 2:30 PM

2.52% (1D)

Keine Daten verfügbar

Geld	21.41
Marktkapitalisierung	n/a
Fondsvermögen	29.1 Mio
NAV	43.45
Beta	0.99
EPS (ttm)	k.A.
PE Ratio (ttm)	36.72
Ausstehende Anteile	k.A.
Auflagedatum	Feb 25, 2020

Brief	64.23
Volumen	157
Ø Vol. (20D)	2,519
Eröffnung	43.11
Vortagesschluss	42.44
Tagesspanne	43.11 - 43.11
52-Wk Range	29.32 - 43.11
Positionen	k.A.
Kostenquote	0.50%

Über HELX

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Anlageklasse Equity

Tickersymbol HELX

Auflagedatum Feb 25, 2020

Anbieter Franklin Templeton Investments

Website Fonds-Homepage

Börse Cboe US

Top Sektoren

Sektor	Gewicht %
Healthcare	96.44%
Basic Materials	2.65%
Technology	0.91%

Alle Sektoren anzeigen

Top 10 Positionen 47.90% insgesamt

Name	Symbol	Gewicht
Guardant Health Inc	GH	10.09%
Natera Inc	NTRA	7.57%
Krystal Biotech Inc	KRYS	5.97%
Ligand Pharmaceutica...	LGND	4.32%
Adaptive Biotechnolo...	ADPT	4.32%
Bridgebio Pharma Inc	BBIO	3.87%
United Therapeutics ...	UTHR	3.45%
Eli Lilly And Co	LLY	2.91%
Vertex Pharmaceutica...	VRTX	2.71%
Samsung Biologics Co...	207940.KS	2.69%

Alle Positionen anzeigen

Dividenden Dividendenrendite 0.33%

Ex-Dividende	Betrag	Zahldatum
Dec 30, 2025	$0.1430	k.A.
Dec 30, 2021	$0.0040	k.A.
Dec 13, 2021	$0.1140	k.A.
Dec 14, 2020	$0.0520	k.A.

Vollständige Dividendenhistorie

Nachrichten

vor 2 Monaten · MarketBeat

3 ETFs For the Coming Genomics Revolution

Genomics companies are an exciting frontier in health care, and ETFs can help to diversify to control risk while positioning investors to benefit.